Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Yahoo/Reuters
Mon, 11/4/24 - 06:58 pm
Vertex Pharmaceuticals
earnings
cystic fibrosis
In pain R&D, Vertex withstood tough times to bring non-opioid suzetrigine to cusp of FDA approval
Fierce Biotech
Mon, 10/28/24 - 10:20 am
Vertex Pharmaceuticals
R&D
non-opioid pain treatments
suzetrigine
Editas cashes in on portion of Vertex gene editing licensing agreement for $57M
Fierce Biotech
Fri, 10/4/24 - 09:24 am
Editas Medicine
Cas9
patents
Vertex Pharmaceuticals
gene editing
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Wed, 10/2/24 - 11:24 am
FDA
Bridge Bio
acoramidis
AstraZeneca
Daiichi Sankyo
Dato-DXd
Vertex Pharmaceuticals
Vanza Triple
PTC Therapeutics
Upstaza
Bristol Myers Squibb
Opdivo
Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy
Fierce Pharma
Tue, 09/24/24 - 09:51 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Lonza
Casgevy
Is anyone taking the world’s priciest drugs?
Pharma Voice
Fri, 08/30/24 - 11:28 am
drug prices
gene therapy
CRISPR Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
Bluebird stock plummets 18% with slow uptake of sickle cell disease gene therapy Lyfgenia
Fierce Pharma
Wed, 08/14/24 - 10:31 pm
Bluebird Bio
sickle cell disease
Vertex Pharmaceuticals
Lyfgenia
Casgevy
Vertex lifts sales guidance as launch of gene therapy Casgevy picks up steam
Fierce Pharma
Fri, 08/2/24 - 11:52 am
Vertex Pharmaceuticals
gene therapy
Casgvey
earnings
Vertex gets January 30 decision date for non-opioid pain med suzetrigine
Businesswire
Tue, 07/30/24 - 06:40 pm
Vertex Pharmaceuticals
suzetrigine
non-opioid pain treatments
FDA
Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex
BioPharma Dive
Tue, 07/16/24 - 12:06 pm
Sionna Therapeutics
cystic fibrosis
AbbVie
Vertex Pharmaceuticals
Vertex sues U.S. government over access to fertility support services for Casgevy patients
Stat
Mon, 07/15/24 - 11:13 pm
Vertex Pharmaceuticals
Fertility
CRISPR
Casgevy
Vertex clinches Trikafta and other cystic fibrosis drug reimbursement deal in England
Fierce Pharma
Fri, 06/21/24 - 11:42 am
Vertex Pharmaceuticals
UK
NHS
Trikafta
Symkevi
Orkambi
cystic fibrosis
Vertex presents longer-term data that shows durability and consistency of Casgevy
Fierce Pharma
Fri, 06/14/24 - 11:30 am
Vertex Pharmaceuticals
sickle cell disease
FDA
Casgevy
Companies to watch for potential M&As in 2024
BioSpace
Wed, 06/5/24 - 11:31 am
M&A
Vertex Pharmaceuticals
Regeneron
Biogen
Moderna Therapeutics
Who Will the Next “Big Pharma” Players Be?
BioSpace
Wed, 05/29/24 - 11:21 am
Big Pharma
Vertex Pharmaceuticals
Regeneron
Moderna Therapeutics
Zoetis
BioNTech
In gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts
Fierce Pharma
Thu, 05/9/24 - 07:17 pm
gene therapy
Vertex Pharmaceuticals
Bluebird Bio
Vertex files FDA approval ask for next-gen cystic fibrosis candidate, resumes diabetes cell therapy trial
Fierce Biotech
Tue, 05/7/24 - 11:14 am
Vertex Pharmaceuticals
cystic fibrosis
Vanza Triple
FDA
gene therapy
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Reuters
Mon, 05/6/24 - 05:53 pm
Vertex Pharmaceuticals
earnings
cystic fibrosis
Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche
Fierce Pharma
Wed, 04/24/24 - 08:50 am
orphan drugs
Evaluate Pharma
JNJ
Vertex Pharmaceuticals
Roche
Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem
NASDAQ.com
Tue, 04/23/24 - 09:51 pm
Vertex Pharmaceuticals
TreeFrog Therapeutics
cell therapy
type 1 diabetes
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »